<DOC>
	<DOCNO>NCT00208130</DOCNO>
	<brief_summary>The primary objective study investigate safety efficacy topiramate treatment PTSD woman survivor domestic violence and/or rape trauma measure Clinician-Administered PTSD Scale ( CAPS ) DSM-IV .</brief_summary>
	<brief_title>Topiramate Treatment Posttraumatic Stress Disorder Civilians</brief_title>
	<detailed_description>Psychopharmacologic treatment PTSD inform limited empirical data . Prior recently complete multi-site trial sertraline conduct Pearlstein colleague find efficacy woman men suffer chronic PTSD , handful publish randomize controlled trial . An overview literature suggest tricyclic antidepressant , monoamine inhibitor selective seratonin reuptake inhibitor ( SSRIs ) show promise , usually good response civilian PTSD male veteran combat-related PTSD . Although result open-label study alpha-2 agonist , beta blocker , anticonvulsant , mood stabilize agent appear promising , present one agent emerge useful broad range PTSD sufferer . This single-center , outpatient , randomize , double-blind , placebo-controlled , parallel group study design evaluate safety efficacy topiramate treat PTSD civilian trauma . This study conduct 60 subject diagnosis PTSD define DSM-IV criterion . Thirty subject assign topiramate 30 assign placebo .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>1 . Subjects must diagnosis PTSD define DSMIV least six month , support Structured Clinical Interview DSMIV Axis I Disorders ( SCIDI ) . 2 . Subjects must female 19 64 year age , inclusive . 3 . Subjects must minimum past week CAPS score 50 Visit 2 ( Day 1 ) . 4 . Subjects must generally good health confirm medical history , baseline psychiatric history physical examination , include vital sign . 5 . Subjects must observe designate washout period prohibit medication outline Concomitant Therapy section protocol . 6 . Subjects must negative urine drug screening ( phencyclidine , cocaine , amphetamine , tetrahydrocannabinol , opiate ) Visit 1 . 7 . Subjects must : 1. postmenopausal least one year , 2. hysterectomy tubal ligation otherwise incapable pregnancy , 3. practice one follow method contraception least one month prior study entry : hormonal contraceptive , spermicide barrier , intrauterine device , spousal/partner sterility 4. practicing abstinence agree continue abstinence use acceptable method contraception ( list ) sexual activity commence . If ( c ) ( ) , subject must negative urine pregnancy test one week prior Visit 2 ( Day 1 ) . 8 . Subjects must able take oral medication , adhere medication regimens willing return regular visit . 9 . Subjects must able read comprehend write instruction willing complete scale inventory require protocol . 1 . Subjects DSMIV diagnosis substance dependence abuse ( exception nicotine caffeine dependence ) within past 3 month . 2 . Subjects current past history primary major depressive disorder major anxiety disorder ( i.e. , panic disorder , obsessivecompulsive disorder , social phobia ) define DSMIV . 3 . Subjects current lifetime history schizophrenia , bipolar disorder , psychotic disorder define DSMIV . 4 . Subjects DSMIV diagnosis current organic mental disorder , factitious disorder , malinger . 5 . Subjects currently enrol cognitivebehavioral therapy program . Note : Subjects may receive concurrent psychotherapy ( cognitivebehavioral therapy ) , subject must initiate new psychotherapy treatment participation trial . 6 . Subjects prior nonresponse topiramate treatment PTSD follow adequate trial . 7 . Subjects disability compensation claim pending lack function due PTSD . 8 . Subjects disability compensation dependent persist functional impairment relate PTSD . 9 . Subjects previously treat topiramate discontinue treatment due adverse event subject know hypersensitivity topiramate . 10 . Subjects clinically unstable disease : cardiovascular , renal , gastrointestinal , pulmonary , metabolic , endocrine systemic disease could interfere participation study . 11 . Subjects history nephrolithiasis . 12 . Subjects SGOT and/or SGPT level great 2 time upper limit normal range Screening . 13 . Subjects active liver disease . 14 . Subjects take antipsychotic within three month screen visit . 15 . Subjects progressive degenerative neurologic disorder ( e.g. , multiple sclerosis ) .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>PTSD</keyword>
	<keyword>trauma</keyword>
</DOC>